Researcher profile
Sagnik Bhattacharyya
Affiliations
Organizations
Centro de Investigación Biomédica en Red de Salud Mentalauthorship · ESKing's College Londonauthorship · GBLambeth Hospitalauthorship · GBNational Institute for Health and Care Researchauthorship · GBSouth London and Maudsley NHS Foundation Trustauthorship · GBUniversitat de Barcelonaauthorship · ESUniversity of Londonauthorship · GB
Public evidence
20 connected articles
The Autism-Psychosis Continuum Conundrum: Exploring the Role of the Endocannabinoid System.2022 · Europe PMCIs It Time to Test the Antiseizure Potential of Palmitoylethanolamide in Human Studies? A Systematic Review of Preclinical Evidence.2022 · Europe PMCEye movements in patients in early psychosis with and without a history of cannabis use.2021 · PubMed Central Open AccessAre researchers getting the terms used to denote different types of recreational cannabis right?-a user perspective.2021 · Europe PMCIs the Adolescent Brain at Greater Vulnerability to the Effects of Cannabis? A Narrative Review of the Evidence.2020 · PubMed Central Open AccessCannabis: Neuropsychiatry and Its Effects on Brain and Behavior.2020 · PubMed Central Open AccessEffects of short-term cannabidiol treatment on response to social stress in subjects at clinical high risk of developing psychosis.2020 · Europe PMCCannabis use in patients with early psychosis is associated with alterations in putamen and thalamic shape.2020 · PubMed Central Open AccessAssociation of cannabis with glutamatergic levels in patients with early psychosis: Evidence for altered volume striatal glutamate relationships in patients with a history of cannabis use in early psychosis.2020 · PubMed Central Open AccessA Systematic Review of Human Neuroimaging Evidence of Memory-Related Functional Alterations Associated with Cannabis Use Complemented with Preclinical and Human Evidence of Memory Performance Alterations.2020 · PubMed Central Open AccessUnraveling the Intoxicating and Therapeutic Effects of Cannabis Ingredients on Psychosis and Cognition.2020 · Europe PMCDescriptive Psychopathology of the Acute Effects of Intravenous Delta-9-Tetrahydrocannabinol Administration in Humans.2019 · Europe PMCRegular cannabis use is associated with altered activation of central executive and default mode networks even after prolonged abstinence in adolescent users: Results from a complementary meta-analysis.2019 · PubMed Central Open AccessDisrupted parahippocampal and midbrain function underlie slower verbal learning in adolescent-onset regular cannabis use.2019 · PubMed Central Open AccessDelta-9-tetrahydrocannabinol increases striatal glutamate levels in healthy individuals: implications for psychosis.2019 · PubMed Central Open AccessCannabidiol attenuates insular dysfunction during motivational salience processing in subjects at clinical high risk for psychosis.2019 · Europe PMCDoes Cannabis Composition Matter? Differential Effects of Delta-9-tetrahydrocannabinol and Cannabidiol on Human Cognition.2017 · Europe PMCPoor medication adherence and risk of relapse associated with continued cannabis use in patients with first-episode psychosis: a prospective analysis.2017 · PubMed Central Open AccessAssociation of cannabis use with hospital admission and antipsychotic treatment failure in first episode psychosis: an observational study.2016 · PubMed Central Open AccessStructural and Functional Imaging Studies in Chronic Cannabis Users: A Systematic Review of Adolescent and Adult Findings2013 · PubMed Central Open Access
Registered research
Connected studies
A Visuomotor Rotation Task as a Biomarker of Cerebellar Dysfunction in Chronic Cannabis Usenct03662737Effects of Cannabidiol (CBD) on the Brainnct04831294Testing the Efficacy of the Cannabis Clinic for Patients With Psychosis (CCP) Intervention for Cannabis Use Reduction/Cessation in Patients With First Episode Psychosisnct07245212The Supplementation Therapy in Autism and Response to Treatment (START) Studynct06187090
Matched by exact identifiers only. Profile data: Corpus/OpenAlex.